Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.
Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
A recent study showed that an antibiotic stewardship program was associated with a 50 percent reduction in antibiotic prescribing.
Physicians and scientists from Northwestern Medicine and other institutions have banded together to combat COVID-19 misinformation and disinformation.
Northwestern Medicine scientists are expanding the global network of COVID-19 sequencing in regions where there is limited viral genetic information reporting.
The most common test to measure a person’s lung function may be missing many people with impaired lung health, according to a new study.
Damage to particular regions of the brain may influence addiction behaviors, providing insight into potential therapeutic targets for substance use disorders.
A new Northwestern Medicine study found of the new rules issued during a one-year period by the The Joint Commission, many did not appear to be supported by published evidence.